Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Clinical trial NCT04368429 · COMPLETED

Trial details

NCT number: NCT04368429
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Immunisation (Healthy Volunteers)

Start date: 2020-05-22
Primary completion: 2020-11-07
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.